来源：员福好管家 为了更好地解决原研药"医院开不到、院外买得贵"的困境，一款以保障原研药用药需求的团体补充医疗 保险产品悄然破局。 近日，新华人寿保险股份有限公司（以下简称"新华保险"）联合中国人寿再保险股份有限公司（以下简 称"中再寿险"）、上海睿择佑安健康科技有限公司（以下简称"睿择健康）和北京慧保福达健康科技有 限公司（以下简称"慧保福达）四方合力，联合推出一款涵盖原研药的团体医疗保险。该产品以创新 的"保险保障+医疗服务+药品供给"的生态融合模式，与传统团体补充医疗保险形成优势互补，有效解 决了原研药用药保障的难点和痛点。 2025年12月，国家医保局、人社部联合发布了新版基本医保药品目录以及首份商业健康保险创新药品目 录，在新的政策指挥棒下，通过团险方式实现商保创新药多元化直付将成为行业新的重要创新方向。 此次四方的跨界合作，共同构建了"风险保障-诊疗服务-药品配送"的全链条闭环。其中，新华保险依托 在团体保险领域的客户基础与服务经验，提供定制化保障方案设计与理赔服务支撑；中再寿险通过专业 风险定价机制为产品创新提供技术支持，并为该创新产品提供再保险服务；睿择健康与北京慧保福达则 通过整合互联网医院 ...

为了更好地解决原研药"医院开不到、院外买得贵"的困境，一款以保障原研药用药需求的团体补充医疗 保险产品悄然破局。 锚定行业痛点驱动产品创新 此次创新产品的推出，精准回应了国内当前医疗保障领域的核心矛盾，在政策约束与市场需求的交叉点 上寻找创新突破口。 当前，在医保集采政策的大背景下，国内医院的原研药"断供"现象愈发普遍。随着医保集采常态化推 进，仿制药带量采购凭借价格优势成为医院用药主流，原研药因价格因素未中选或者退出集采，逐渐退 出公立医院药品供应体系。 在此趋势下，国内大量对原研药有刚性需求的患者（如肿瘤患者、慢性病患者），面临"医院开不到、 院外买得贵"的困境，这不仅增加了患者经济负担，也大幅加剧了用药可及性焦虑。原研药的供给与需 求矛盾，也为商业健康保险产品提供原研药保障带来了切实的市场需求。 严守诊疗规范，筑牢线上医疗安全防线 近日，新华人寿保险股份有限公司（以下简称"新华保险"）联合中国人寿再保险股份有限公司（以下简 称"中再寿险"）、上海睿择佑安健康科技有限公司（以下简称"睿择健康）和北京慧保福达健康科技有 限公司（以下简称"慧保福达）四方合力，联合推出一款涵盖原研药的团体医疗保险。该产品以创新 ...

Group 1 - The article highlights the importance of chronic disease management and the positive impact of recent policy changes on patients, particularly in terms of financial relief and accessibility to medications [1][2] - There is a concerning trend of chronic diseases becoming more prevalent among younger populations, with individuals in their 30s and 40s increasingly affected, indicating a need for early intervention and awareness [1][2] - The article emphasizes the necessity for a comprehensive approach to chronic disease management that includes prevention, diagnosis, treatment, and ongoing support, aligning with the "Health China" strategy that prioritizes prevention [2][3] Group 2 - The article discusses the role of commercial insurance in enhancing the multi-tiered healthcare system, providing personalized health management services, and addressing gaps in coverage for rare and chronic diseases [3] - It mentions the need for continuous development and implementation of policies to ensure effective chronic disease management and support for patients, highlighting the importance of sustained efforts in healthcare reform [2][3] - The sentiments expressed by patients reflect a recognition of the benefits of current policies and a hopeful outlook for future improvements in healthcare support [3]

近日，"今日保"正式发布第六届中国保险白象榜评选结果。作为聚焦保险行业创新成果与优质服务的重 要榜单，此次评选筛选出兼具市场竞争力与社会价值的保险产品与机构。交银人寿首款税优健康险产品 ——交银人寿惠享安康护理保险凭借精准的政策适配性、全面的保障设计与贴心的民生关怀，成功获 评"年度健康险领航产品"。 该产品适用商业健康保险个人所得税优惠政策，为应税人群提供每年最高2400元的税前抵扣额度，切实 减轻纳税人经济负担；实现终身保障承诺，为被保险人构建长期稳定的风险防护网。在保障责任方面， 产品涵盖护理保险金与疾病身故保险金双重责任，保障范围精准覆盖关键风险场景——若被保险人不幸 确诊10种特定疾病，或因意外伤害事故导致1-3级伤残，可一次性申领护理保险金，有效缓解重大疾病 与重度伤残带来的家庭护理经济压力，为患者后续康复护理提供坚实的资金保障；同时，疾病身故保险 金为被保险人家庭财富传承增添一份安心。 深耕健康险领域，践行金融惠民使命。交银人寿将紧跟国家政策导向，以客户需求为核心，持续优化产 品体系，创新服务模式，推出更多兼具政策适配性与市场实用性的保险产品，为构建多层次、多元化的 健康保障体系贡献更多金融力量 ...

Core Viewpoint - The establishment of the Gansu Traditional Chinese Medicine Industry Association marks a new collaboration platform between the government and the market to promote the development of the traditional Chinese medicine industry in Gansu Province, which has surpassed a scale of 100 billion yuan [1][3]. Group 1: Industry Development - Gansu Province is recognized as a significant birthplace of traditional Chinese medicine and a major production area for authentic medicinal materials [3]. - The association aims to focus on "serving the industry, empowering members, inheriting innovation, and going international" to promote the integration of the entire traditional Chinese medicine industry chain [3][4]. - Gansu has been designated as a national pilot province for comprehensive reform and development of traditional Chinese medicine, with the industry becoming a key area for the province's economic and social development [3]. Group 2: Association Objectives - The newly established association will work on building an international cooperation system for the traditional Chinese medicine industry, leveraging resources from Hong Kong and Macau to transform resource advantages into industrial advantages [4]. - It will promote digitalization and standardization, establish a traceability and quality evaluation system for medicinal materials, and enhance industry self-discipline and integrity [4]. - The association plans to integrate traditional Chinese medicine with culture, tourism, and health industries to enhance brand influence and tell the story of "Long Medicine" [4].

Group 1 - The "2025 Responsibility Shine Qilu" annual health event highlighted the importance of health management and recognized outstanding contributions in the healthcare sector [1] - The event announced the "Top Ten Health News in Shandong" and awarded titles such as "Responsible Hospital," "Responsible Department," and "Responsible Medical Practitioner" [1] - The launch of the "Yidian Ask Doctor" digital doctor service and the initiation of the "Yidian Ask Doctor" national health protection series for 2026 were also key highlights of the event [1] Group 2 - Meinian Health Industry (Shandong) Co., Ltd. was established in 2015 and is part of Meinian Health Industry Holdings Co., Ltd., a leading private healthcare enterprise in China [3] - The company operates under three health examination brands: "Mienian Health," "Ciming," and "Ciming Aoya," with over 40 examination centers across 16 cities in Shandong [3] - Meinian Health serves nearly 3 million health examination clients annually, focusing on health consultation, assessment, and management, supported by a vast network and health data [3]

Core Viewpoint - The "beautiful economy" is thriving in Lishui's Liandu District, with significant developments in the beauty and health industry, including partnerships with major beauty brands and impressive industrial output figures [1][4]. Group 1: Industry Development - Liandu District has signed cooperation agreements with beauty giants Proya and Oushiman, positioning itself as a new hub for the beauty and health industry [4]. - The health industry in Liandu has seen a total industrial output value of 9.837 billion yuan from January to November this year, with expectations to exceed 10.88 billion yuan by 2024 [1][5]. - The district has attracted over 100 upstream and downstream enterprises in the beauty and health industry, forming a collaborative industrial structure led by companies like Naies and Mingye Technology [5]. Group 2: Strategic Initiatives - The local government has implemented several strategic plans, including the "Three-Year Action Plan for the Development of Traditional Chinese Medicine and Health Industry" and the "Development Plan for the Beautiful Health Industry" [7]. - Liandu is focusing on six main sectors: ecological beauty, fashion medical aesthetics, oral healthcare, modern traditional medicine, health tea and coffee, and pet products [7]. - The establishment of innovation centers and industry funds totaling 1 billion yuan aims to enhance project attraction and optimize the beauty and health industry chain [7][8]. Group 3: Future Goals - By 2030, the Liandu District aims to achieve an industrial output value of over 20 billion yuan in the beauty and health sector and cultivate nationally influential innovative enterprises [9]. - The district plans to build the "China Lishui Beautiful Health Port" as a central initiative to drive the development of beauty, health, and emotional economy sectors [9].

Core Viewpoint - The "Tongpu Shenzhou Wuyouxing" initiative, launched by a state-owned medical institution, aims to address the long-standing issue of cross-regional dialysis for patients, enabling them to travel and receive treatment seamlessly across different provinces [1][3][4]. Group 1: Background and Challenges - Nearly 90% of dialysis patients are confined within a 50-kilometer radius of their treatment centers, limiting their ability to travel for family visits or vacations [2]. - The challenges faced by dialysis patients include inconsistent treatment standards across regions, lack of information sharing between medical institutions, and barriers in medical insurance for cross-regional treatment [2][8]. Group 2: Implementation and Innovations - The initiative began with a professional meeting in November 2024, where a proposal was made to facilitate travel for dialysis patients, leading to the development of standardized documentation and processes for patient transfer [3][6]. - A comprehensive set of standardized documents was created within three weeks, covering all aspects from pre-travel assessments to emergency procedures, supported by a network of nearly 400 medical institutions across 28 provinces [3][6]. Group 3: Patient Experiences and Outcomes - As of December 15, 2024, the first patient, Aunt Jiang, successfully received dialysis treatment in Chengdu, demonstrating the effectiveness of the initiative in providing seamless care [4][5]. - By October 2025, the program had assisted 32 patients with 110 instances of cross-regional dialysis, achieving a 100% satisfaction rate among participants [5][6]. Group 4: Systemic Impact and Future Directions - The initiative represents a model for improving healthcare quality and accessibility, emphasizing the importance of life quality enhancement for patients beyond mere survival [7]. - The program's success highlights the potential for replicable pathways in addressing cross-regional medical collaboration challenges, with implications for broader healthcare reforms in China [7][8].

Core Viewpoint - Ping An Good Doctor has been awarded the "Annual Outstanding Healthcare Enterprise" by Gelonghui, recognizing its innovative Chinese-style Health Maintenance Organization (HMO) model and future potential in addressing challenges in the healthcare system [1] Group 1: Strategic Positioning - The company's core competitiveness stems from its strategic anchoring, positioning itself as a builder of the Chinese version of HMO, unlike many industry players focused on e-commerce or online consultations [1][2] - The business model has shifted from "post-reimbursement" to "full-cycle health management," aiming for a win-win scenario of "health preservation and cost control" through deep integration of payment and services [1][2] Group 2: Technological Empowerment - Ping An Good Doctor integrates AI deeply into its services, utilizing its self-developed medical model "Ping An Yibo Tong" to create a comprehensive "7+N+1" AI product matrix [2] - The application of AI has significantly improved the quality and efficiency of professional medical services, with the accuracy of complex disease treatment plans rising to nearly 90% and home doctor service costs decreasing by approximately 52% year-on-year [2] Group 3: Ecosystem Advantages - The company benefits from a robust ecosystem built on the Ping An Group, providing seamless services across various channels: online, hospital, home, and enterprise [3][4][5] - The extensive cooperation network includes nearly 37,000 hospitals in China and top global institutions, ensuring efficient resource matching through AI [4] - The company has provided comprehensive health management services to over 56,000 enterprises and 26 million employees, creating a low-cost customer acquisition model and high-value retention [5] Group 4: Future Growth Prospects - The award signifies market recognition of Ping An Good Doctor's Chinese-style management healthcare path, pointing towards a broader growth blueprint [6] - The company is poised to benefit from the structural growth period in the commercial health insurance market, which currently accounts for less than 3% of the healthcare payment structure in China [8] - With the "Healthy China" strategy advancing, enterprise health management is becoming a core competitive advantage, and Ping An Good Doctor has established significant first-mover and scale advantages in this area [8] Group 5: Long-term Vision - The growth narrative follows a clear logic of "internal to external, capability spillover," with the company focusing on serving internal insurance and enterprise clients while accumulating data capabilities [9] - Future plans include leveraging internal service networks and operational efficiencies to expand into external markets, potentially providing health management solutions to government healthcare systems [9][10] - The capital market is expected to reassess the company's value, given its roots in a larger and more urgent Chinese market compared to its U.S. counterparts, with a current market value of approximately 28.3 billion yuan [10] Summary - The recognition of Ping An Good Doctor as an "Annual Outstanding Healthcare Enterprise" highlights its successful exploration of a technology-driven management healthcare model [11] - The company has established a differentiated development path through a clear HMO strategy, deep AI integration, and unique ecosystem collaboration, aligning with market expectations for more efficient and accessible healthcare services [11]

Core Insights - The article highlights the successful implementation of the "ECG One Network" project in Suqian City's Suyu District, which aims to enhance the grassroots healthcare service system and improve medical service efficiency for residents [1][2]. Group 1: Project Implementation and Impact - The "ECG One Network" project was launched to address challenges such as insufficient ECG diagnostic capabilities and difficulties in emergency response at grassroots medical institutions [1]. - The project has been piloted in 42 village health institutions across 10 towns, significantly improving medical service efficiency and convenience for residents [1]. - Since its launch in July, the project has provided convenient medical services to over 3,000 individuals, identifying 9 critical cases of acute myocardial infarction with a diagnostic accuracy rate of 100% [1]. Group 2: Technological Integration and Benefits - The project utilizes digital technology to create a seamless connection between grassroots medical institutions and higher-level hospitals, allowing for real-time data uploads and remote diagnosis by specialists [1]. - This integration has reduced the need for patients to travel long distances for complex cardiac treatments, thereby saving critical time in emergency situations [1]. - The initiative has not only improved work efficiency for healthcare providers but has also enhanced patient outcomes, as evidenced by the successful management of critical cases [1][2]. Group 3: Future Directions - The Suyu District Health Bureau plans to continue implementing the "ECG One Network" and other beneficial projects to further enhance the service capabilities of grassroots medical institutions [2]. - The focus will remain on integrating resources and improving service quality to provide better healthcare for the community [2].